Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA
ACS Nano · 14.02.2023 · 17 (3) · 2588-2601
DOI: 10.1021/acsnano.2c10501 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 31.01.2023. Verfasst von Hiroki Tanaka und 20 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba shi, Chiba…. Hauptthemen laut MEDLINE: Liposomes, Nanoparticles. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Hokkaido University, Takeda Science Foundation, Kato Memorial Bioscience Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba shi, Chiba 260-0856, Japan.
- Department of Physical Chemistry, School of Pharmacy and Pharmaceutical Sciences, Hoshi University, 2-4-41 Ebara, Shinagawa-Ku, Tokyo 142-8501, Japan.
- Laboratory of Pharmaceutical Technology, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba shi, Chiba 260-0856, Japan.
- Laboratory of Biomolecular Science and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
- Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, Sanyo-Onoda, Yamaguchi 756-0884, Japan.
- Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
ORCID-Profile: Katsuyuki Chida, Kasumi Sasaki, Etsuo Yonemochi, Keisuke Ueda, Kenjirou Higashi, Kunikazu Moribe, Hidetaka Akita
Förderung
- Hokkaido University
- Takeda Science Foundation
- Kato Memorial Bioscience Foundation
- Core Research for Evolutional Science and Technology
- Japan Agency for Medical Research and Development
- Asahi Glass Foundation
- Japan Society for the Promotion of Science
- NOF CORPORATION
Zitieren
APA
Tanaka, H., Hagiwara, S., Shirane, D., Yamakawa, T., Sato, Y., Matsumoto, C., Ishizaki, K., Hishinuma, M., Chida, K., Sasaki, K., Yonemochi, E., Ueda, K., Higashi, K., Moribe, K., Tadokoro, T., Maenaka, K., Taneichi, S., Nakai, Y., Tange, K., …, & Akita, H. (2023). Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA. ACS Nano, 17(3), 2588-2601. https://doi.org/10.1021/acsnano.2c10501
Vancouver
Tanaka H, Hagiwara S, Shirane D, Yamakawa T, Sato Y, Matsumoto C, et al. Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA. ACS Nano. 2023;17(3):2588-2601. doi:10.1021/acsnano.2c10501
BibTeX
@article{Tanaka2023,
author = {Tanaka, Hiroki and Hagiwara, Shinya and Shirane, Daiki and Yamakawa, Takuma and Sato, Yuka and Matsumoto, Chika and Ishizaki, Kota and Hishinuma, Miho and Chida, Katsuyuki and Sasaki, Kasumi and Yonemochi, Etsuo and Ueda, Keisuke and Higashi, Kenjirou and Moribe, Kunikazu and Tadokoro, Takashi and Maenaka, Katsumi and Taneichi, Sakura and Nakai, Yuta and Tange, Kota and Sakurai, Yu and Akita, Hidetaka},
title = {Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA},
journal = {ACS Nano},
year = {2023},
volume = {17},
number = {3},
pages = {2588--2601},
doi = {10.1021/acsnano.2c10501}
}
EUVIMED